skip to main content
Southern Health NHS Foundation Trust Southern Health Covid-19 Service Changes

Quality of Life Injectable

Quality of Life Injectable

 *COVID-19 UPDATE: Currently paused to recruitment, follow up appointments are continuing.*              

The effect of injectable therapies on health status, quality of life and treatment satisfaction in patients with type 2 diabetes: prospective observational cohort study.

The study involves three contacts with the research team over a period of six months. These study contacts can either be over the phone or in form of face to face study visits at The Research and Development Department, Moorgreen Hospital, depending on preference. This will involve taking the patients’ medical history, diabetes medications, filling out paper questionnaires about their quality of life and treatment satisfaction and recording their height and weight.
Be aged 18+

Diagnosis of type 2 diabetes.

Naïve to self – administered SC injectable diabetes therapy at the point of recruitment.

Patients with type 2 diabetes treated with diet or oral medications only, who are planning to start a new oral diabetes medication or injectable diabetes treatments to improve their diabetes control, are invited to take part in this research study.

If you would like to take part or want more information please contact the study lead:

Study Contact: Liz Houghton


Tel: 023 8047 5258

Page Comments